Created by leading neuromuscular physicians, InCircle Review helps payors and MCOs improve care, minimize waste, and decrease drug spend for expensive therapies like Intravenous Immunoglobulin Therapy (IVIg).
InCircle Review aligns longitudinal patient, diagnostic, and insurance data to streamline the prescribing process and help ensure patients receive the right drug at the right time while providing consistent and transparent decision-making for all stakeholders.
By leveraging the knowledge of a panel of expert reviewers who have access to real data, InCircle Review alleviates the burden on prescribing physicians who are currently tasked with making accurate diagnoses without access to the data and longitudinal records to do so.
In addition, InCircle Review gives payors a transparent and consistent view of the decision-making process, while providing employers with a desperately needed solution to control drug spend.
More About Us
InCircle Review combines the knowledge of key opinion leaders with the data needed to make the right prescribing decision, lowering rates of misdiagnosis and prescription overutilization.
Developed by leading neuromuscular physicians Jonathan Katz, M.D., and Todd Levine, M.D., InCircle Review helps payors and MCOs improve care, minimize waste, and decrease drug spend for expensive therapies like Intravenous Immunoglobulin Therapy (IVIg) with the help of a proprietary algorithm-based approach to match the right drug with the right patient.
We provide transparent and consistent communication that minimizes misdiagnosis and improves clinical outcomes for patients with complex neurological disorders.
The Idea Behind InCircle Review
The idea for InCircle Review followed the findings of the largest review of immunoglobulin specialty drug therapy utilization.
The INSIGHTS study included a review of 248 patient progress notes, lab data, and electrodiagnostic studies supplied to insurance companies for IVIG in neuropathy. The compiled data, which included referrals from 154 physicians in 26 states, produced findings that were troubling:
- Only 32% of patients receiving treatment were determined to actually have an immune neuropathy
- Half of patients diagnosed with neuropathies that were clearly not immune-mediated
- Only 15% clearly met electrodiagnostic criteria for a demyelinating neuropathy
So, we set out to create a solution that would be better for insurers, providers, and patients.
Spurred by a desire to improve IG prescription accuracy, the core team at InCircle Review began strategizing to develop an algorithm-based approach that would capture only the most vital patient data and essentially match the right drug to the right patient.
The InCircle Review solution eliminates the need to involve MDs in the decision-making process, while leveraging the experience and knowledge of a panel of expert reviewers who have access to real data.
Solutions and Next Steps
InCircle Review is poised to revolutionize the cumbersome IG review process, deliver longitudinal patient tracking information,
provide open access to accurate data, and fundamentally transform the way IG is prescribed.
It also facilitates a significant process improvement by shortening the time for approvals, ultimately reducing the overall drug spend – a win-win for physicians, payors and specialty drug manufacturers.
Meet Our Team
Todd Levine, M.D.
Board Certified Neurologist
Todd Dylan Levine, MD received his medical degree from Duke University in Durham, North Carolina. He completed a residency in Neurology and a Fellowship in Neuromuscular Disease at Washington University School of Medicine in St. Louis, Missouri, and has been a specialist in Neuromuscular disorders for the past 20 years.
Dr. Levine currently serves as the Director of the Neurology Department at Honor Health in Phoenix Arizona, is the founder of the multi-disciplinary ALS Clinic, and is one of the founders of Corinthian Reference Labs and Cutaneous Neurodiagnostic, a national reference labs dedicated to using skin biopsies for diagnosing neurologic disorders such as Parkinson’s Disease and Alzheimer’s Disease.
Dr. Levine is board certified by the American Board of Psychiatry and Neurology and the American Board of Electrodiagnostic Medicine. He is a fellow of the American Association of Neuromuscular and Electrodiagnostic Medicine and a member of the American Academy of Neurology. He is the past Chairman of the Neuromuscular division of the American Academy of Neurology and the Arizona State Liaison for the American Academy of Neuroelectrodiagnostic Medicine. Dr. Levine conducts extensive research in diseases of the nerve and muscle. He has published his findings in numerous peer-reviewed journals and lectures both nationally and internationally on these disorders.
Jonathan S. Katz, M.D.
Board Certified Neurologist
Dr. Katz currently practices Neurology in San Francisco, and is Board Certified in Adult Neurology by the American Board of Psychiatry and Neurology and a member of the American Academy of Neurology.
Dr. Katz is President of the ALS Research Group and serves on the National Medical Advisory Boards for the Myasthenia Gravis Foundation and the Guillain-Barre Syndrome Foundation International.
Honored as one of The Best Doctors in America, Dr. Katz also serves as Adjunct Professor in Neurology at Kansas University. He co-conceived the InCircle concept with Dr Levine, and currently serves as an advisor for further algorithm development.
Suzette DiMascio, CHE, CMCE, CPC
Executive Vice President
As an innovator, thought leader, sought-after keynote speaker and educator on all things Specialty Pharmacy & Rare/Orphan Disease-related, Suzette is recognized internationally as a trusted advisor that accelerates business growth while possessing a relentless drive to transform patient care. A self-described Passionate Patient Advocate, Suzette has demonstrated success in delivering cross-functional solutions to increase Patient Choice and Access across the healthcare continuum.
As a reflection of her dedication to the industry & servant leadership philosophy, Suzette received APPA’s Hall of Fame Award, honoring the ways she champions to improve patient care & access, as well as mentoring women through the Women in Specialty Pharmacy Organization she founded in 2013. Suzette also serves as a volunteer on the Executive team for the HBA Global Ambassador Program, as a worldwide advocate for Diversity and Inclusion, thriving on inspiring and mentoring up-and-coming leaders.
In addition to serving as a Board Member for NASP, HBA & the State of FL Innovation Caucus, Suzette also serves as an Advisory Board Member for Atlas Health and SpringHealth Live, two up and coming patient technology solutions. Appointed by Gov. Rick Scott to the FL Board of Employee Leasing, the rigorous selection process to be appointed to a State Board is a true testament to Ms. DiMascio’s stellar ethical reputation in the industry she has served for over 25 years.
Invited by the Governor’s office to spearhead FL’s Talent Caucus, she was 1 of 50 women selected to participate in a Prestigious Executive Leadership Program at Tuck School of Business-Dartmouth & was 1 of only 14 women to receive the Dorothy Brothers Scholarship award by WBENC.
Suzette founded CSI Specialty Group In 2002, serving as President/CEO for 17 years. Under her leadership, honors include being named as one of Consulting Magazine’s Fastest Growing Firms, Goldman Sach’s Top Growing Businesses & recipient for an unprecedented 4 years in a row, of the coveted Commonwealth Institute’s Top 50 Women Led Business, from 2014-2018.
Can InCircle Review Work for You?
Take this 2-minute assessment to determine if InCircle Review can work for you.